Investor

BioMedInvest

Last cheque observed Jan 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series BSeries ASeries D

Cheques on record
0%of best year0cheques in 12 months, 11 on record
Since the last cheque4309days00hrs00min00sec
Median round$18MRounds led0 of 11Exits3 from the portfolioMostly inGermany, 50%
Pitch BioMedInvest

BioMedInvest highlights

  1. 01

    11 rounds on record

  2. 02

    Mostly Series B and Series A: 82% of its rounds

  3. 03

    3 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first11 appearances

  1. 2015

    2 rounds

  2. Jan
    Miracor Medical Systems GmbHSeries B · AT$5.3MWith 3 others
  3. Jan
    GenkyotexSeries D · CH$21MWith 5 others
  4. 2014

    2 rounds

  5. Nov
    CuretisSeries B · DE$18MWith 6 others
  6. Sept
    Affimed TherapeuticsSeries E · DE$16MWith 2 others
  7. 2009

    1 round

  8. Aug
    SpinelabSeries B · CH$10MWith 2 others
  9. 2008

    2 rounds

  10. Sept
    LumavitaSeries A · CH$16MWith 2 others
  11. Jul
    SuppreMolSeries B · DE$25MWith 5 others
  12. 2007

    1 round

  13. Apr
    Affimed TherapeuticsSeries B · DE$32MWith 3 others
  14. 2005

    1 round

  15. Aug
    AvontecSeries B · DE$18MWith 3 others
  16. 2004

    1 round

  17. Mar
    CareX SASeries B · FR$32MWith 5 others
  18. 2003

    1 round

  19. Nov
    Glycart Biotechnology AGSeries A$14MWith 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed3 in all

SuppreMolBought by Baxter InternationalUndisclosedMar 2015
CareX SABought by 7TM PharmaUndisclosedMay 2006
Glycart Biotechnology AGBought by RocheUndisclosedJul 2005

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as BioMedInvest. A count of rooms they were both in, not a relationship either has claimed.

EQT life sciencePrivate equity3rounds togetherAeris CapitalGrowth equity2rounds togetherDVC Deutsche Venture CapitalGrowth equity2rounds togetherGlobal Life Science VenturesGrowth equity2rounds togetherVI PartnersVC firm2rounds together

Quick answers about BioMedInvest

What does BioMedInvest invest in?

BioMedInvest invests most often at Series B and Series A (82% of the rounds on record).

How active is BioMedInvest?

11 investments on record, 0 of them in the last 12 months. The most recent was in Jan 2015.

How big are BioMedInvest's cheques?

The median round it joins is $18M.

Does BioMedInvest lead rounds?

Rarely, if at all: none of its 11 investments on record names it as the lead.

Where does BioMedInvest invest?

Most of the companies it backs are in Germany (50%), Switzerland (30%) and Austria (10%).

Is BioMedInvest investing now?

No investments in the last 12 months; the latest was in Jan 2015.

Who does BioMedInvest invest alongside?

Most often EQT life science (3 rounds together), Aeris Capital (2 rounds together) and DVC Deutsche Venture Capital (2 rounds together).

What kind of investor is BioMedInvest?

BioMedInvest is a growth equity firm.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it